U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07167823) titled 'The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront' on Sept. 03.
Brief Summary: Empyema is a problem that thoracic surgeons deal in everyday practice. The main goal of treatment is evacuating the pus and fibrin deposits in the thoracic cavity for complete lung expansion. This study aims to report a detailed microbiological profile of patients operated for empyema thoracis and also correlate it with perioperative clinical outcomes. Patients who underwent surgery for empyema thoracis between January 2022 to June 2025 were included in the study. This study was carried out at two ...